IP Library Granted Patent US 7,374,747
Granted Patent B2
US 7,374,747 · App. 11/463,573 · Granted May 20, 2008

Pharmaceutical foam

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,374,747
App. No.
11/463,573
Granted
May 20, 2008
Kind
B2
Abstract

The present invention provides various pharmaceutically active topical delivery compositions. In particular, compositions of the present invention are present in a pressurized contained comprising a quick-breaking alcoholic foaming agent, such that when the composition is released, i.e., dispensed, from the pressurized container, a quick-breaking temperature sensitive foam is formed. In addition, the present invention provides various aspects related to such compositions, including methods for modulating a foam characteristic, methods for improving the shelf-life of a pharmaceutically active compound, methods for the percutaneous treatment of various diseases, infections, and illnesses, and methods for evaluating foam characteristics.

Claims (25)

1. A method for treating a bacteria-mediated disease, said method comprising:

applying a quick-breaking temperature sensitive foam composition to the skin of a subject in need thereof, said composition comprising:

up to 15% w/w of clindamycin phosphate;

from about 83% to about 97.9% w/w of a quick-breaking foaming agent, wherein said quick-breaking foaming agent comprises a C 1 -C 6 alcohol, a C 14 -C22 alcohol, water, and a surfactant;

from about 2% to about 7% w/w of an aerosol propellant selected from the group consisting of a hydrocarbon, a chlorofluorocarbon, dimethyl ether, hydrofluorocarbons and a mixture thereof; and

a base, to treat said bacteria-mediated disease.

2. The method of claim 1 , wherein the amount of said C 1 -C 6 alcohol in said quick-breaking foaming agent is from about 55% to about 65% w/w.

3. The method of claim 1 , wherein the ratio of said C 1 -C 6 alcohol to water is from about 1:7 to about 1:16.

4. The method of claim 1 , wherein the ratio of said C 1 -C 6 alcohol to water is less than about 1:7.

5. The method of claim 1 , wherein the ratio of said C 1 -C 6 alcohol to water is about 1.5:1 to about 1.8:1.

6. The method of claim 1 , wherein the ratio of said C 1 -C 6 alcohol to water is about 1.55:1 to about 1.75:1.

7. The method of claim 1 , wherein the ratio of said C 1 -C 6 alcohol to water is from about 1.5:1.

8. The method of claim 1 , wherein said surfactant is present in an amount of from about 0.1% to about 10% w/w.

9. The method of claim 1 , wherein said surfactant is selected from the group consisting of an ethoxylated non-ionic surfactant, an ethoxylated ionic surfactant, and a mixture thereof.

10. The method of claim 1 , wherein said C 1 -C 6 alcohol is ethanol.

11. The method of claim 1 , wherein said C 1 -C 6 alcohol is a mixture of ethanol and at least one other C 1 -C 6 alcohol.

12. The method of claim 1 , wherein the amount of said C 14 -C 22 alcohol in said quick-breaking foaming agent is from about 1% to about 5% w/w.

13. The method of claim 12 , wherein said C 14 -C 22 alcohol is a C 14 -C 20 alcohol.

14. The method of claim 13 , wherein said C 14 -C 20 alcohol is selected from the group consisting of cetyl alcohol, stearyl alcohol, and a mixture thereof.

15. The method of claim 14 , wherein said C 14 -C 20 alcohol is a mixture of cetyl alcohol and stearyl alcohol.

16. The method of claim 1 , wherein said surfactant is a polysorbate.

17. The method of claim 1 , further comprising an emollient.

18. The method of claim 1 , wherein said base is a member selected from the group consisting of a bicarbonate, a carbonate, an alkali hydroxide, an alkaline earth metal hydroxide, and a transition metal hydroxide.

19. The method of claim 18 , wherein said base wherein said base is potassium hydroxide.

20. The method of claim 1 , wherein said bacteria-mediated disease is acne vulgaris.